Structural modification and biological evaluation of spirolactone type ent-kauranoid isodonal as potential anti-melanoma agents.

Authors

Siyuan Huo, Yangyang Fu, Bingchao Yan, Yixue Shao, Cailing Qiu, Zhaojun Yang, Qian Guo, Zijin Hu, Tao Jiao, Handong Sun, Pematenzin Puno

Published in

Fitoterapia. Pages 107181. Mar 16, 2026. Epub Mar 16, 2026.

Abstract

Malignant melanoma is an aggressive cancer requiring new therapeutic options. Isodonal, a known spirolactone type ent-kauranoid, was obtained in high abundance from Isodon oresbius. Phenotypic screening of isodonal revealed its antiproliferative activity against A375 melanoma cells. In the structural modification to prompt its selection for optimization, we synthesized a focused library of thirty new ester derivatives (8-37) at C-6 position of isodonal. All analogues exhibited enhanced potency (IC₅₀ = 0.73-4.43 μM) over isodonal, with the C-6 4-fluorocinnamate ester 29 being most potent (IC₅₀ = 0.73 μM; ~10-fold improvement). Structure-activity relationship analysis revealed that conjugated systems (e.g., cinnamoyl) boost activity, and that specific substitutions in benzoate derivatives can modulate selectivity between melanoma and normal cells. Compound 29 was found to suppress proliferation, induce apoptosis and G2/M phase arrest, and elevate ROS levels in A375 cells. This study delivers a potent lead compound and a framework for the natural product-inspired development of anti-melanoma therapeutics.

PMID:
41850593
Bibliographic data and abstract were imported from PubMed on 19 Mar 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.